https://nl.marketscreener.com/koers/aandeel/BIO-THERA-SOLUTIONS-LTD-103374480/nieuws/Bio-Thera-Solutions-Ltd-kondigt-eerste-dosis-aan-in-Fase-1-studie-voor-Bat8009-een-antilichaamcon-41179653/?utm_source=telegram&utm_medium=social&utm_campaign=share